Literature DB >> 11953909

Moving dipole analysis of normal and abnormal ventricular activation by magnetocardiography.

Yasunaga Hiyoshi1, Harumizu Sakurada, Naomi Izumida, Seiko Kawano, Tohru Sawanobori, Masayasu Hiraoka.   

Abstract

The current source during ventricular excitation of the in situ heart has not been well characterized. We analyzed current dipoles of ventricular excitation by magnetocardiography (MCG) in 16 healthy subjects and 10 patients with the Wolff-Parkinson-White syndrome or premature ventricular contraction. Single current dipoles were estimated by MCG with the spatial position, direction, and strength in the initial 40 ms of QRS (moving dipole analysis). In 12 of the 16 healthy subjects, the origin of current dipoles moved consecutively from the initial position with the increase in the peak strength at 30 ms of QRS. In the other 4 healthy subjects, dipoles moved discontinuously jumping to the right-anterior thorax at 17.8 ms (mean). In abnormal ventricular excitation, the dipoles remained in the initial position with little movement, smaller strength of dipole than that of normal with a delayed peak time. The moving dipole analysis can be applied to determine spatial distribution of normal and abnormal excitation sources at the initial phase of ventricular depolarization in the in situ heart.

Entities:  

Mesh:

Year:  2002        PMID: 11953909     DOI: 10.1054/jelc.2002.32335

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  Genetic algorithms for dipole location of fetal magnetocardiography.

Authors:  D Escalona-Vargas; P Murphy; C L Lowery; H Eswaran
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2016-08

2.  Classifying cases of fetal Wolff-Parkinson-White syndrome by estimating the accessory pathway from fetal magnetocardiograms.

Authors:  A Kandori; T Hosono; Y Chiba; M Shinto; S Miyashita; M Murakami; T Miyashita; K Ogata; K Tsukada
Journal:  Med Biol Eng Comput       Date:  2003-01       Impact factor: 2.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.